Related Experiment Video

Updated: Aug 18, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

Enhanced expression of type I interferon and toll-like receptor-3 in primary biliary cirrhosis

Yasushi Takii1, Minoru Nakamura, Masahiro Ito

  • 1Clinical Research Center, National Hospital Organization Nagasaki Medical Center, Nagasaki 856-8562, Japan.

Laboratory Investigation; a Journal of Technical Methods and Pathology
|April 28, 2005
PubMed

Insights

Toll-like receptor 3 (TLR-3) and type I interferon (IFN) signaling are active in early primary biliary cirrhosis (PBC). These pathways are implicated in the disease

Area of Science:

  • Immunology
  • Hepatology
  • Molecular Biology

Background:

  • The exact causes of primary biliary cirrhosis (PBC) are not fully understood.
  • Investigating molecular pathways involved in PBC pathogenesis is crucial for understanding the disease.

Purpose of the Study:

  • To analyze the site-specific expression of cytokines and toll-like receptors (TLRs) in early-stage PBC.
  • To investigate the role of type I interferons (IFNs) and TLR-3 in PBC pathophysiology.

Main Methods:

  • Laser capture microdissection and real-time reverse transcription-polymerase chain reaction (RT-PCR) were used to quantify mRNA expression.
  • Immunohistochemistry was employed to detect protein expression of IFN-alpha, IFN-beta, and TLR-3.
  • Autoimmune hepatitis (AIH) and chronic hepatitis C (CHC) were used as disease controls.

Main Results:

  • Significantly higher mRNA levels of type I IFNs (IFN-alpha, -beta) and TLR-3 were observed in the portal tract and liver parenchyma of PBC patients compared to controls.
  • A strong positive correlation was found between type I IFN and TLR-3 mRNA levels.
  • IFN-alpha, IFN-beta, and TLR-3 proteins were detected in specific liver cells, including mononuclear cells, sinusoidal cells, macrophages, and hepatocytes.
  • IFN-alpha mRNA levels in the portal tract correlated positively with serum alkaline phosphatase levels.

Conclusions:

  • Toll-like receptor 3 (TLR-3) and type I interferon (IFN) signaling pathways are demonstrably active in both the portal tract and liver parenchyma in early-stage PBC.
  • These findings support a hypothesis that TLR-3 and type I IFN signaling play a significant role in the underlying pathophysiology of primary biliary cirrhosis.

More Related Videos

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF311:44

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3

Published on: January 24, 2016

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...